VF
IMPL

Virtu Financial’s Impel Pharmaceuticals Inc. Common Stock IMPL Stock Holding History

Virtu Financial’s Portfolio IMPL Stock Details IMPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-16,112
Closed -$7K – 2203
2023
Q3 		$7K Buy
+16,112
New +$15.5K ﹤0.01% 1133
2021
Q4 		– Sell
-11,381
Closed -$139K – 2312
2021
Q3 		$139K Buy
+11,381
New +$165K 0.01% 1031

Other funds holding IMPL

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
DJSG
D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return

Virtu Financial's IMPL Position: Q4 2023 in Review

Virtu Financial sold out of Impel Pharmaceuticals Inc. Common Stock (IMPL) in Q4 2023, closing a stake of 16,112 shares — an estimated $7K sold.

Virtu Financial first reported a position in IMPL in Q3 2021 and held it in 2 quarters. The position peaked at $139K in Q3 2021. 2 funds tracked by Wall St. Rank hold IMPL as of Q4 2023.

  • Virtu Financial reported no remaining Impel Pharmaceuticals Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Virtu Financial sold 16,112 Impel Pharmaceuticals Inc. Common Stock shares in Q4 2023, an estimated $7K.
  • Virtu Financial first reported a position in Impel Pharmaceuticals Inc. Common Stock in Q3 2021 and held it in 2 quarters.
  • Virtu Financial's Impel Pharmaceuticals Inc. Common Stock position peaked at $139K in Q3 2021.
  • 2 funds tracked by Wall St. Rank held Impel Pharmaceuticals Inc. Common Stock as of Q4 2023.

Based on Virtu Financial's 13F filing for Q4 2023, filed 26 Feb 2024.